100 related articles for article (PubMed ID: 23134917)
1. Serum zinc level and prostatic lesion.
Rahman MT; Mumu MA; Kabir Y; Choudhury MM; Saiedullah M
Mymensingh Med J; 2012 Oct; 21(4):679-83. PubMed ID: 23134917
[TBL] [Abstract][Full Text] [Related]
2. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
Tarle M; Kraljić I
Anticancer Res; 1997; 17(3A):1531-4. PubMed ID: 9179191
[TBL] [Abstract][Full Text] [Related]
3. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ
J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
Pacelli A; Bostwick DG
Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen density: the role in benign prostate hyperplasia, prostate intraepithelial neoplasm, organ-confined prostate carcinoma and advanced prostate carcinoma.
Işikay L; Yaman O ; Bozlu M; Müftüğlu YZ; Göğüş O
Int Urol Nephrol; 1995; 27(6):757-61. PubMed ID: 8725043
[TBL] [Abstract][Full Text] [Related]
6. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
Helpap B; Riede C
Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
[TBL] [Abstract][Full Text] [Related]
7. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
[TBL] [Abstract][Full Text] [Related]
8. Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate.
Helpap B
Pathol Res Pract; 1995 Sep; 191(9):904-7. PubMed ID: 8606872
[TBL] [Abstract][Full Text] [Related]
9. Zinc plasma levels in prostatic carcinoma and BPH.
Lekili M; Ergen A; Celebi I
Int Urol Nephrol; 1991; 23(2):151-4. PubMed ID: 1713903
[TBL] [Abstract][Full Text] [Related]
10. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens.
Qian J; Bostwick DG
Pathol Res Pract; 1995 Sep; 191(9):860-7. PubMed ID: 8606866
[TBL] [Abstract][Full Text] [Related]
11. Circulating neuroendocrine markers in patients with prostate carcinoma.
Berruti A; Dogliotti L; Mosca A; Bellina M; Mari M; Torta M; Tarabuzzi R; Bollito E; Fontana D; Angeli A
Cancer; 2000 Jun; 88(11):2590-7. PubMed ID: 10861438
[TBL] [Abstract][Full Text] [Related]
12. Prostate tissue and serum markers.
Mazzucchelli R; Colanzi P; Pomante R; Muzzonigro G; Montironi R
Adv Clin Path; 2000 Jul; 4(3):111-20. PubMed ID: 11080790
[TBL] [Abstract][Full Text] [Related]
13. [Influence of prostatic intraepithelial neoplasia on blood levels of PSA and free PSA percentage].
Morote J; López M; de Torres IM; de Torres JA
Actas Urol Esp; 1999 Apr; 23(4):342-9. PubMed ID: 10394655
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of the expression of epidermal growth factor receptor in benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatic carcinoma.
Rana S; Sen R; Kalra R; Arora B; Sharma P; Gahlawat S
Indian J Pathol Microbiol; 2006 Oct; 49(4):495-9. PubMed ID: 17183836
[TBL] [Abstract][Full Text] [Related]
15. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
Goel T; Garg S
Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
[TBL] [Abstract][Full Text] [Related]
16. [A proteomic study of the serum proteins in BPH and HGPIN patients].
Gu XJ; Zhu QY; Yuan L; Su J; Huang WZ; Zhang Y; Sun ZY
Zhonghua Nan Ke Xue; 2008 Jan; 14(1):62-6. PubMed ID: 18297816
[TBL] [Abstract][Full Text] [Related]
17. A unifying hypothesis that links benign prostatic hyperplasia and prostatic intraepithelial neoplasia with prostate cancer. Invited comments.
Harvey H
Pathol Res Pract; 1995 Sep; 191(9):924-34. PubMed ID: 8606875
[TBL] [Abstract][Full Text] [Related]
18. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
[TBL] [Abstract][Full Text] [Related]
19. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
[TBL] [Abstract][Full Text] [Related]
20. [The use of ProstaDoz in patients with benign prostatic hyperplasia and coexistent high-grade prostatic intraepithelial neoplasia].
Antonov AG; Gordeev VV; Fedorchuk SB; Laptev DO
Urologiia; 2017 Oct; (5):58-62. PubMed ID: 29135144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
